Entelexo Biotherapeutics

Supplier

Summarized by Halo AI

Entelexo Biotherapeutics is a biotechnology company developing a proprietary platform to engineer therapeutic exosomes that treat complex autoimmune diseases by simultaneously targeting multiple diseased cell types.

Company size

Less than 500 employees

Revenue

~$5M (2024)

Portfolio summary

Engineered exosomes for indication-specific biotherapeutics

Markets served

Entelexo Biotherapeutics is a privately held biotechnology/pharmaceutical manufacturing company founded in 2020 and headquartered in Irvine, California. It focuses on developing modern treatments for complex autoimmune diseases using engineered exosome technology and data-driven optimization approaches.

AI summary generated on Jun 22, 2026

OpenAlex

For general inquiries

Milad Riazifar

CEO

Is this page yours? Boost its visibility

List technologies, facilities, services, or grant collaboration opportunities.

Entelexo Biotherapeutics

For general inquiries

Looking for

Key links